首页> 外文OA文献 >EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma

【2h】

EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma

机译：Epha5突变预测肺腺癌患者免疫检查点抑制剂的持久临床效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Weimei Huang; Anqi Lin; Peng Luo; Yuchen Liu; Wentao Xu; Weiliang Zhu; Ting Wei; Qingwen Lyu; Linlang Guo; Jian Zhang;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma [J] . Huang Weimei, Lin Anqi, Luo Peng, Cancer gene therapy . 2021,第7期

机译：Epha5突变预测肺腺癌患者免疫检查点抑制剂的持久临床效益
2. Identification and validation of significant gene mutations to predict clinical benefit of immune checkpoint inhibitors in lung adenocarcinoma [J] . Ying Chen, Shaoyi Miao, Wancheng Zhao American Journal of Translational Research . 2021,第3期

机译：重大基因突变的鉴定与验证，以预测肺腺癌免疫检查点抑制剂的临床益处
3. Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinoma [J] . Progress in Artificial Intelligence . 2020,第1期

机译：基于体细胞突变的深度神经网络分类可能预测免疫检查点阻断肺腺癌的临床益处
4. Compactness Measures of Tumor Infiltrating Lymphocytes in Lung Adenocarcinomas are associated with Overall Patient Survival and Immune Scores [C] . Ruiwen Ding, Prateek Prasanna, Germán Corredor, Conference on Medical Imaging: Digital Pathology . 2020

机译：肺腺癌肿瘤浸润淋巴细胞的紧凑性测量与整体患者存活和免疫分数有关
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinoma [O] . Jie Peng, Dan Zou, Wuxing Gong, 2020

机译：基于体细胞突变的深度神经网络分类有可能预测肺腺癌免疫检查点封锁的临床益处
7. Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer [O] . Eun Hee Jung, Hee Ryung Jang, Se Hyun Kim, 2020

机译：肿瘤LAG-3和NY-ESO-1表达预测晚期非小细胞肺癌免疫检查点抑制剂的耐用临床益处

EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅